Serum amyloid A (SAA)-induced remodeling of CSF-HDL

Shadlen, 2000, The epidemiology of Alzheimer's disease and vascular dementia in Japanese and African-American populations: the search for etiological clues, Neurobiol. Aging, 21, 171, 10.1016/S0197-4580(00)00115-9 Ueda, 1992, Prevalence and etiology of dementia in a Japanese community, Stroke, 23, 798, 10.1161/01.STR.23.6.798 Hatada, 1999, Further evidence of westernization of dementia prevalence in Nagasaki, Japan, and family recognition, Int. Psychogeriatr., 11, 123, 10.1017/S1041610299005682 Selkoe, 2001, Alzheimer's disease: genes, proteins, and therapy, Physiol. Rev., 81, 741, 10.1152/physrev.2001.81.2.741 Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 Haass, 1992, Amyloid β-peptide is produced by cultured cells during normal metabolism, Nature, 359, 322, 10.1038/359322a0 Busciglio, 1993, Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells, Proc. Natl. Acad. Sci. U. S. A., 90, 2092, 10.1073/pnas.90.5.2092 Allinson, 2003, ADAMs family members as amyloid precursor protein alpha-secretases, J. Neurosci. Res., 74, 342, 10.1002/jnr.10737 Koudinov, 1996, Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins, Biochem. Biophys. Res. Commun., 223, 592, 10.1006/bbrc.1996.0940 Roheim, 1979, Apolipoproteins in human cerebrospinal fluid, Proc. Natl. Acad. Sci. U. S. A., 76, 4646, 10.1073/pnas.76.9.4646 Yamauchi, 1999, Apolipoprotein E in cerebrospinal fluid: relation to phenotype and plasma apolipoprotein E concentrations, Clin. Chem., 45, 497, 10.1093/clinchem/45.4.497 Miida, 1999, The apolipoprotein E content of HDL in cerebrospinal fluid is higher in children than in adults, Clin. Chem., 45, 1294, 10.1093/clinchem/45.8.1294 Narita, 1997, The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development, J. Neurochem., 68, 587, 10.1046/j.1471-4159.1997.68020587.x Kim, 1996, Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain, J. Biol. Chem., 271, 8373, 10.1074/jbc.271.14.8373 Willnow, 1996, Defective forebrain development in mice lacking gp330/megalin, Proc. Natl. Acad. Sci. U. S. A., 93, 8460, 10.1073/pnas.93.16.8460 Taira, 2001, LR11, A mosaic LDL receptor family member, mediates the uptake of apo E-rich lipoproteins in vitro, Arterioscler. Thromb. Vasc. Biol., 21, 1501, 10.1161/hq0901.094500 Yamauchi, 1999, Higher avidity binding of apolipoprotein (E-AII) complex than apolipoprotein E monomer to β-amyloid, J. Neurosci. Res., 58, 301, 10.1002/(SICI)1097-4547(19991015)58:2<301::AID-JNR10>3.0.CO;2-9 Koudinov, 2001, The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology?, Neurosci. Lett., 314, 115, 10.1016/S0304-3940(01)02263-7 Uhlar, 1999, Serum amyloid A, the major vertebrate acute-phase reactant, Eur. J. Biochem., 265, 501, 10.1046/j.1432-1327.1999.00657.x Meek, 1994, Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function, Proc. Natl. Acad. Sci. U. S. A., 91, 3186, 10.1073/pnas.91.8.3186 Urieli-Shoval, 1998, Widespread expression of serum amyloid A in histologically normal human tissues, Predominant localization to the epithelium, J. Histochem. Cytochem., 46, 1377, 10.1177/002215549804601206 Yamada, 1996, Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions, Pathol. Int., 46, 797, 10.1111/j.1440-1827.1996.tb03552.x Kindy, 1999, Apolipoprotein serum amyloid A in Alzheimer's disease, J. Alzheimer's Dis., 1, 155, 10.3233/JAD-1999-1303 Liang, 1997, Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain, Neurosci. Lett., 225, 73, 10.1016/S0304-3940(97)00196-1 Miida, 1999, Serum amyloid A protein generates preβ1 high-density lipoprotein from α-migrating high-density lipoprotein, Biochemistry, 38, 16958, 10.1021/bi9913045 Yamada, 1994, Fibril formation from recombinant human serum amyloid A, Biochim. Biophys. Acta, 1226, 323, 10.1016/0925-4439(94)90044-2 Hirayama, 2005, Effect of apolipoprotein E (apoE) phenotype on the apoE content of CSF-HDL in children, Clin. Chim. Acta, 356, 110, 10.1016/j.cccn.2005.01.004 Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 Yamada, 2000, Serum amyloid A secretion from monocytic leukaemia cell line THP-1 and cultured human peripheral monocytes, Scand. J. Immunol., 52, 7, 10.1046/j.1365-3083.2000.00734.x Eto, 1986, A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populations, Clin. Genet., 30, 422, 10.1111/j.1399-0004.1986.tb01901.x Miida, 1996, Preβ1-high-density lipoprotein increases in coronary artery disease, Clin. Chem., 42, 1992, 10.1093/clinchem/42.12.1992 Miida, 2000, Bezafibrate increases preβ1-HDL at the expense of HDL2b in hypertriglyceridemia, Arterioscler. Thromb. Vasc. Biol., 20, 2428, 10.1161/01.ATV.20.11.2428 Miida, 2003, LCAT-dependent conversion of preβ1-HDL into α-migrating HDL is severely delayed in hemodialysis patients, J. Am. Soc. Nephrol., 14, 732, 10.1097/01.ASN.0000046962.43220.8A Miida, 2003, Analytical performance of a sandwich enzyme immunoassay for preβ1-HDL in stabilized plasma, J. Lipid Res., 44, 645, 10.1194/jlr.D200025-JLR200 Miyazaki, 2000, A new sandwich enzyme immunoassay for measurement of plasma pre-β1-HDL levels, J. Lipid Res., 41, 2083, 10.1016/S0022-2275(20)32370-1 Gahtan, 1999, Inflammatory pathogenesis in Alzheimer's disease: biological mechanisms and cognitive sequeli, Neurosci. Biobehav. Rev., 23, 615, 10.1016/S0149-7634(98)00058-X Gylys, 2003, Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-β protein into synaptic terminals, J. Neurochem., 84, 1442, 10.1046/j.1471-4159.2003.01643.x Bauer, 1991, Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices, FEBS Lett., 285, 111, 10.1016/0014-5793(91)80737-N Griffin, 1989, Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease, Proc. Natl. Acad. Sci. U. S. A., 86, 7611, 10.1073/pnas.86.19.7611 Tarkowski, 1999, Intracerebral production of tumour necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia, J. Clin. Immunol., 4, 223, 10.1023/A:1020568013953 Guo, 2002, Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis, J. Neurosci., 22, 5900, 10.1523/JNEUROSCI.22-14-05900.2002 Demeester, 2000, Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease, J. Lipid Res., 41, 963, 10.1016/S0022-2275(20)32039-3 Yokoyama, 1985, Behavior of human apolipoprotein E in aqueous solutions and at interfaces, J. Biol. Chem., 260, 16375, 10.1016/S0021-9258(17)36247-6 Tokuda, 2000, Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid β peptides, Biochem. J., 348, 359, 10.1042/bj3480359 Rocchi, 2003, Causative and susceptibility genes for Alzheimer's disease: a review, Brain Res. Bull., 61, 1, 10.1016/S0361-9230(03)00067-4 Brewer, 1972, Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex, Proc. Natl. Acad. Sci. U. S. A., 69, 1304, 10.1073/pnas.69.5.1304 Weisgraber, 1978, Apoprotein (E-A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction, J. Biol. Chem., 253, 6281, 10.1016/S0021-9258(17)34612-4 Tozuka, 1992, Identification and characterization of apolipoprotein(AII–E2–AII) complex in human plasma lipoprotein, Biochim. Biophys. Acta, 1165, 61, 10.1016/0005-2760(92)90076-8 Saito, 2004, Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins, Prog. Lipid Res., 43, 350, 10.1016/j.plipres.2004.05.002 Lagocki, 1980, In vitro modulation of the apolipoprotein composition of high density lipoprotein. Displacement of apolipoprotein A-I from high density lipoprotein by apolipoprotein A-II, J. Biol. Chem., 255, 3701, 10.1016/S0021-9258(19)85761-7 Murdoch, 1994, Development of a density gradient ultracentrifugation technique for the resolution of plasma lipoproteins which avoids apo E dissociation, Anal. Biochem., 222, 427, 10.1006/abio.1994.1512